Matsuda Masaru

Insider·Arcutis Biotherapeutics, Inc.·ARQT·Insider since 2025·Form 4 filings: 15
Trades YTD
4
Trades (12m)
11
Net position
Current holdings
P-code buys (12m)
0
Cluster
None

Transaction history · last 12 months

11 transactions
02 Feb 2026
SOLD
$ARQT
4,714
$25.63
S
02 Feb 2026
SOLD
$ARQT
19,379
$25.24
S
02 Feb 2026
SOLD
$ARQT
8,562
$24.97
S
02 Feb 2026
SOLD
$ARQT
7,983
$25.50
S
01 Dec 2025
SOLD
$ARQT
1,657
$30.23
S
19 Nov 2025
SOLD
$ARQT
1,561
$28.50
S
19 Nov 2025
SOLD
$ARQT
989
$27.95
S
03 Nov 2025
SOLD
$ARQT
43
$25.40
S
03 Nov 2025
SOLD
$ARQT
7,165
$24.71
S
04 Sep 2025
SOLD
$ARQT
36,130
$16.16
S
04 Aug 2025
SOLD
$ARQT
6,330
$14.33
S

Transaction codes: P open-market purchase · S sale · M option exercise · A grant.

Cluster context · Arcutis Biotherapeutics, Inc.

last 30 days

No active insider cluster at Arcutis Biotherapeutics, Inc. in the last 30 days. Masaru's recent transactions appear in the section above.

Convergence · Pattern Engine ships in v1.1

30-day window
In development

Convergence participation lands with the Pattern Engine.

Once the Pattern Engine ships, this section will list every active convergence event Masaru is named in — the hedge funds and Congress members on the same name, the 30-day window, and the combined position size.

Context

Form 4 background

Form 4 filings are required within two business days of any insider transaction by an officer, director, or 10%+ shareholder. Open-market purchases (transaction code P) are the most signal-rich because they indicate the insider is paying market price with personal cash — as distinct from option exercises, scheduled sales, or compensation grants. Cluster buying — three or more insiders of the same company buying open-market shares in a 30-day window — has historically been one of the strongest positive insider-trading signals in the academic literature.

Source data: SEC EDGAR · Form 4 filings · Last refreshed 11:11 UTC.